D(T)PACE as salvage therapy for aggressive or refractory multiple myeloma von Gerrie, Alina S., Mikhael, Joseph R., Cheng, Lu, Jiang, Haiyan, Kukreti, Vishal, Panzarella, Tony, Reece, Donna, Stewart, Keith A., Trieu, Young, Trudel, Suzanne, Chen, Christine I.

Volltext

The Bcl-2 Family Protein Inhibitor, ABT-737, Has Substantial Antimyeloma Activity and Shows Synergistic Effect with Dexamethasone and Melphalan von TRUDEL, Suzanne, STEWART, A. Keith, ZHIHUA LI, YANJUN SHU, LIANG, Sheng-Ben, TRIEU, Young, REECE, Donna, PATERSON, Josh, DINGYAN WANG, WEN, Xiao-Yan

Volltext

Clinical Outcomes in t(4;14) Multiple Myeloma: A Chemotherapy-Sensitive Disease Characterized by Rapid Relapse and Alkylating Agent Resistance von Jaksic, Wilfrid, Trudel, Suzanne, Chang, Hong, Trieu, Young, Qi, Xi, Mikhael, Joseph, Reece, Donna, Chen, Christine, Stewart, A Keith

Volltext

The SH3-SAM adaptor HACS1 is up-regulated in B cell activation signaling cascades von Zhu, Yuan Xiao, Benn, Sally, Li, Zhi Hua, Wei, Ellen, Masih-Khan, Esther, Trieu, Young, Bali, Meenakshi, McGlade, C Jane, Claudio, Jaime O, Stewart, A Keith

Volltext

Weekly Cyclophosphamide and Alternate-Day Prednisone: An Effective, Convenient, and Well-Tolerated Oral Treatment for Relapsed Multiple Myeloma After Autologous Stem Cell Transplan... von TRIEU, YOUNG, TRUDEL, SUZANNE, POND, GREGORY R., MIKHAEL, JOSEPH, JAKSIC, WILFRID, REECE, DONNA E., CHEN, CHRISTINE I., STEWART, A. KEITH

Volltext

Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13 von Reece, Donna, Song, Kevin W., Fu, Tommy, Roland, Birgitte, Chang, Hong, Horsman, Douglas E., Mansoor, Adnan, Chen, Christine, Masih-Khan, Esther, Trieu, Young, Bruyere, Helene, Stewart, Douglas A., Bahlis, Nizar J.

Volltext

Impact of cytogenetics in patients with relapsed or refractory multiple myeloma treated with bortezomib: Adverse effect of 1q21 gains von Chang, Hong, Trieu, Young, Qi, Xiaoying, Jiang, Nan N, Xu, Wei, Reece, Donna

Volltext

Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed/refractory multiple myeloma von Chang, Hong, Trieu, Young, Qi, Xiaoying, Xu, Wei, Stewart, Keith A, Reece, Donna

Volltext

Treatment of relapsed/refractory multiple myeloma with weekly cyclophosphamide plus bortezomib plus prednisone or dexamethasone (CyBor-P/D): Updated experience at Princess Margaret... von Reece, Donna Ellen, Trieu, Young, Masih-Khan, Esther, Chen, Christine, Kukreti, Vishal, Rodriguez, Giovanni Piza, Tiedemann, Rodger Edwin, Trudel, Suzanne

Volltext

Cyclophosphamide and bortezomib with prednisone or dexamethasone for the treatment of relapsed and refractory multiple myeloma von Reece, Donna E, Trieu, Young, Masih-Khan, Esther, Atenafu, Eshetu G, Chen, Christine, Prica, Anca, Tiedemann, Rodger, Trudel, Suzanne, Kukreti, Vishal

Volltext

Multiple myeloma patients with CKS1B gene amplification have a shorter progression‐free survival post‐autologous stem cell transplantation von Chang, Hong, Qi, Xiaoying, Trieu, Young, Xu, Wei, Reader, Jocelyn C., Ning, Yi, Reece, Donna

Volltext

Secondary Myelodysplastic Syndrome/Acute Myeloblastic Leukemia During Lenalidomide-Based Regimens in Relapsed and/or Refractory Multiple Myeloma Patients: Single Center Experience von Kotchetkov, Rouslan, Masih-Khan, Esther, Chu, Chia-Min, Trieu, Young, Dean, Saima, Maganti, Manjula, Chen, Christine I., Kukreti, Vishal, Trudel, Suzanne, Reece, Donna E.

Volltext

Prognostic Relevance of Genomic Aberrations In Light Chain Only Multiple Myeloma von Jiang, Nan, Qi, Connie, Trieu, Young, Reece, Donna E., Chang, Hong

Volltext

Sequencing Novel Agents in Relapsed/Refractory Multiple Myeloma: Use of Bortezomib-Based Therapy After Lenalidomide + Dexamethasone von Reece, Donna E., Trieu, Young, Chen, Christine, Kukreti, Vishal, Xu, Wei, Anglin, Peter, Trudel, Suzanne

Volltext

Impact of Cytogenetic Abnormalities On Outcome Among Patients with Relapsed/Refractory Multiple Myeloma Treated with Bortezomib: Adverse Effect of 1q21 (CKS1B) Amplification von Chang, Hong, Trieu, Young, Qi, Connie, Xu, Wei, Reece, Donna E.

Volltext

Low Risk of Reactivation of Hepatitis B and Hepatic Injury in Multiple Myeloma (MM) Patients (pts) Undergoing Autologous Stem Cell Transplant (ASCT) von Chen, Christine, Trieu, Young, Xu, Wei, Trudel, Suzanne, Kukreti, Vishal, Anglin, Peter, Reece, Donna E.

Volltext

Rapidity and Quality of Response to Steroid-Based Induction Therapy, Without the Addition of Novel Agents, Does Not Affect Post Transplant Outcomes in Multiple Myeloma von Prica, Anca, Trieu, Young, Xu, Wei, Reece, Donna E, Trudel, Suzanne, Kukreti, Vishal, Chen, Christine

Volltext

Molecular Target Characterization and Antimyeloma Activity of the Novel, Insulin-like Growth Factor 1 Receptor Inhibitor, GTx-134 von LIANG, Sheng-Ben, YANG, Xiu-Zhi, GEORGE FANTUS, Ivan, TRUDEL, Suzanne, TRIEU, Young, ZHIHUA LI, ZIVE, Jessica, LEUNG-HAGESTEIJN, Chungyee, WEI, Ellen, ZOZULYA, Sergey, COSS, Christopher C, DALTON, James T

Volltext

Efficacy of thalidomide‐based therapy following lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma von Kukreti, Vishal, Masih‐Khan, Esther, Young, Trieu, Chu, Chia‐Min, Jiang, Haiyun, Trudel, Suzanne, Chen, Christine, Jimenez‐Zepeda, Victor, Reece, Donna E.

Volltext

Relationship of Treatment Effects On Hemoglobin and M-Protein Levels in Relapsed or Refractory Multiple Myeloma: Final Analysis of a Retrospective Chart Review Study von Reece, Donna E., Zaman, Faraz, Trieu, Young, Rodriguez, Giovanni Piza, Teixeira, Bruno, Yoong, Kim, Camacho, Fernando, Plante, Richard K

Volltext